Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?

The treatment of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has undergone several recent advancements, leading to an increased amount of treatment options for relapsed patients. The development of immunotherapies such as anti-CD19 chimeric antigen receptor(CAR) T cells and bispecific T-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Pariury, Holly, Truscott, Laurel, Katsanis, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312595/
https://www.ncbi.nlm.nih.gov/pubmed/34367735
http://dx.doi.org/10.1080/2162402X.2021.1956125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312595/
https://www.ncbi.nlm.nih.gov/pubmed/34367735
http://dx.doi.org/10.1080/2162402X.2021.1956125

Ejemplares similares